These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7507231)

  • 21. The association of human papillomavirus type 16 E6 and E7 antibodies with stage of cervical cancer.
    Fisher SG; Benitez-Bribiesca L; Nindl I; Stockfleth E; Muller M; Wolf H; Perez-Garcia F; Guzman-Gaona J; Gutierrez-Delgado F; Irvin W; Gissmann L
    Gynecol Oncol; 1996 Apr; 61(1):73-8. PubMed ID: 8626121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Notch1 can contribute to viral-induced transformation of primary human keratinocytes.
    Lathion S; Schaper J; Beard P; Raj K
    Cancer Res; 2003 Dec; 63(24):8687-94. PubMed ID: 14695182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies against linear and conformational epitopes of the human papillomavirus (HPV) type 16 E6 and E7 oncoproteins in sera of cervical cancer patients.
    Nindl I; Benitez-Bribiesca L; Berumen J; Farmanara N; Fisher S; Gross G; Lopez-Carillo L; Müller M; Tommasino M; Vazquez-Curiel A
    Arch Virol; 1994; 137(3-4):341-53. PubMed ID: 7524466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human papillomavirus type 18 E6 and E7 antibodies in human sera: increased anti-E7 prevalence in cervical cancer patients.
    Bleul C; Müller M; Frank R; Gausepohl H; Koldovsky U; Mgaya HN; Luande J; Pawlita M; ter Meulen J; Viscidi R
    J Clin Microbiol; 1991 Aug; 29(8):1579-88. PubMed ID: 1722219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of peptide enzyme-linked immunosorbent assay and radioimmunoprecipitation assay with in vitro-translated proteins for detection of serum antibodies to human papillomavirus type 16 E6 and E7 proteins.
    Sun Y; Shah KV; Müller M; Muñoz N; Bosch XF; Viscidi RP
    J Clin Microbiol; 1994 Sep; 32(9):2216-20. PubMed ID: 7529250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of fluorogenic histocompatibility leukocyte antigen-A*0201/HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous human papillomavirus antigens.
    Youde SJ; Dunbar PR; Evans EM; Fiander AN; Borysiewicz LK; Cerundolo V; Man S
    Cancer Res; 2000 Jan; 60(2):365-71. PubMed ID: 10667589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological and clinical responses in women with vulval intraepithelial neoplasia vaccinated with a vaccinia virus encoding human papillomavirus 16/18 oncoproteins.
    Davidson EJ; Boswell CM; Sehr P; Pawlita M; Tomlinson AE; McVey RJ; Dobson J; Roberts JS; Hickling J; Kitchener HC; Stern PL
    Cancer Res; 2003 Sep; 63(18):6032-41. PubMed ID: 14522932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequent display of human papillomavirus type 16 E6-specific memory t-Helper cells in the healthy population as witness of previous viral encounter.
    Welters MJ; de Jong A; van den Eeden SJ; van der Hulst JM; Kwappenberg KM; Hassane S; Franken KL; Drijfhout JW; Fleuren GJ; Kenter G; Melief CJ; Offringa R; van der Burg SH
    Cancer Res; 2003 Feb; 63(3):636-41. PubMed ID: 12566307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides.
    Ressing ME; Sette A; Brandt RM; Ruppert J; Wentworth PA; Hartman M; Oseroff C; Grey HM; Melief CJ; Kast WM
    J Immunol; 1995 Jun; 154(11):5934-43. PubMed ID: 7538538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in cervical-carcinoma patients from Russia.
    Zumbach K; Kisseljov F; Sacharova O; Shaichaev G; Semjonova L; Pavlova L; Pawlita M
    Int J Cancer; 2000 Feb; 85(3):313-8. PubMed ID: 10652419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.
    Walboomers JM; Jacobs MV; Manos MM; Bosch FX; Kummer JA; Shah KV; Snijders PJ; Peto J; Meijer CJ; Muñoz N
    J Pathol; 1999 Sep; 189(1):12-9. PubMed ID: 10451482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein intrinsic disorder and human papillomaviruses: increased amount of disorder in E6 and E7 oncoproteins from high risk HPVs.
    Uversky VN; Roman A; Oldfield CJ; Dunker AK
    J Proteome Res; 2006 Aug; 5(8):1829-42. PubMed ID: 16889404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of antibodies against human papillomavirus type 16 E6 and E7 proteins in sera of patients with cervical neoplasias.
    Sasagawa T; Inoue M; Tanizawa O; Yutsudo M; Hakura A
    Jpn J Cancer Res; 1992 Jul; 83(7):705-13. PubMed ID: 1325428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicted alpha-helix/beta-sheet secondary structures for the zinc-binding motifs of human papillomavirus E7 and E6 proteins by consensus prediction averaging and spectroscopic studies of E7.
    Ullman CG; Haris PI; Galloway DA; Emery VC; Perkins SJ
    Biochem J; 1996 Oct; 319 ( Pt 1)(Pt 1):229-39. PubMed ID: 8870673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors and survival by HPV-16 E6 and E7 antibody status in human papillomavirus positive head and neck cancer.
    Smith EM; Pawlita M; Rubenstein LM; Haugen TH; Hamsikova E; Turek LP
    Int J Cancer; 2010 Jul; 127(1):111-7. PubMed ID: 19876924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer.
    Müller M; Viscidi RP; Sun Y; Guerrero E; Hill PM; Shah F; Bosch FX; Muñoz N; Gissmann L; Shah KV
    Virology; 1992 Apr; 187(2):508-14. PubMed ID: 1312268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of B epitopes in human papillomavirus type 16 E7 open reading frame protein.
    Tindle RW; Smith JA; Geysen HM; Selvey LA; Frazer IH
    J Gen Virol; 1990 Jun; 71 ( Pt 6)():1347-54. PubMed ID: 1693666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of ELISA and western blotting for human papillomavirus type 16 E7 antibody determination.
    Suchánková A; Ritterová L; Krcmár M; Krchnák V; Vágner J; Jochmus I; Gissmann L; Kanka J; Vonka V
    J Gen Virol; 1991 Oct; 72 ( Pt 10)():2577-81. PubMed ID: 1655964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioinformatics analysis of HPV-68 E6 and E7 oncoproteins for designing a therapeutic epitope vaccine against HPV infection.
    Dong D; Zhu Y; Aili Z; Chen Z; Ding J
    Infect Genet Evol; 2020 Jul; 81():104266. PubMed ID: 32114254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of seroreactive regions of the human papillomavirus type 16 protein E4, E6, E7 and L1.
    Müller M; Gausepohl H; de Martynoff G; Frank R; Brasseur R; Gissmann L
    J Gen Virol; 1990 Nov; 71 ( Pt 11)():2709-17. PubMed ID: 1701482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.